Our company is a company at the forefront of neuroscience and cognitive science, producing high-tech AI-based devices to enhance the life quality of patients with neurologic and mental disorders. We specialize in developing a new device, called Epiphany, for drug-resistant epilepsy to monitor the patients and detect the emerging seizure attack. It could also be used to identify the origin of seizures in patients by using several electrodes that do not need to be implanted into the patient's brain. We hope this will help them live their lives more freely and make it easier for doctors to offer treatments.
We want to improve people's lives by creating lifelong diagnostic tools that keep improving, thanks to our deep understanding of neural networks and artificial intelligence. Epiphany is a first-of-its-kind wearable device designed specifically for everyone with drug-resistant epilepsy. The epiphany device uses advanced signal processing technology to read neural activity through several small electrodes placed on the scalp and then transmits this signal wirelessly to a smartphone. The exclusive application installed on the smartphone processes the signals via AI algorithms to find out if a seizure attack is emerging.
Company Details
- Employees
- 3
- Address
- Mashhad, Ir
- Industry
- Mental Health Care
- NAICS
-
Offices of Mental Health Practitioners (except Physicians)
- HQ
- Mashhad
Neurosina Questions
Neurosina's LinkedIn profile is https://ir.linkedin.com/company/neurosina
Neurosina has
3 employees.
View email and phone details for 3
employees at Neurosina.
Neurosina's industry is
Mental Health Care
Neurosina's top competitors are
Student’s Scientific Association Of Mindset,
Souma Pardaz,
Cattleisoin,
Kodalab,
National Cultural Industries And Science And Technology Park,
Ternav,
Plan With Flow,
Veerasense,
Kolnegar,
Ranoidea Iran.
Neurosina's categories are Mental Health Care
